C7D-23790-60322
5 vaccinations
16 coded responses
38 check-ins
15 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 206 / MD
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Immediate post-injection reaction, Throat irritation — Feeling: Fair · Site: Pain, Redness · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Itchy throat 30 minutes after vaccine lasting 12 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Chills, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: Fair · Site: Itching · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Bloody noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Nose bleedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — day 7, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
-
2021-04-22
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Tremor — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: ShakingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Epistaxis, Insomnia — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Bloody nose, insomnia with chillsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal discomfort, Insomnia — Feeling: Fair · Chills, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Insomnia and stomach upsetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-06
-
2021-05-13
Survey response — day 21, dose 2MedDRA: Diarrhoea, Fatigue, Hypotension, Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Low BP, exhaustion, diarrhea, migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Survey response — day 28, dose 2MedDRA: Abdominal discomfort, Blood potassium decreased, Hypotension — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Stomach upset, low BP, low potassiumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-27
Survey response — day 35, dose 2MedDRA: Bladder discomfort, Diarrhoea, Dysuria, Pyrexia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Low grade fever, diarrhea, bladder discomfort, urinary painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-27
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-03
-
2021-07-22
Survey response — 3 months, dose 2MedDRA: Breast mass, Rhinovirus infection, Systemic lupus erythematosus — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Respiratory virus rhinovirus, breast lump needing biopsy determined, SLE diagnosisMedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-24
Call successfulParticipant prefers to complete VAERS report online
-
2021-07-24
Call successfulParticipant prefers to complete VAERS report online
-
2021-07-24
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-17
Dose 3 — Pfizer-BioNTech
-
2021-10-23
Survey response — 6 months, dose 2MedDRA: Nausea, Retinal disorder, Weight decreased — Feeling: Fair · Be unable to work or attend schoolFree text: Weight loss, nausea, retina problemMedDRA releases: 2024-11 · check-in free text available
-
2022-03-26
Dose 4 — Pfizer-BioNTech
-
2022-04-22
Survey response — 12 months, dose 2MedDRA: Epistaxis, Gastrointestinal disorder — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Gastrointestinal complications, nosebleedMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-25
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-26
- 2022-05-02
-
2022-05-09
Survey response — day 42, dose 4MedDRA: Gastrointestinal disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Additional GI complicationsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-09
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-10
- 2022-06-27
-
2022-09-12
Dose 5 — Pfizer-BioNTech
- 2022-09-16
- 2022-09-17
- 2022-09-19
- 2022-09-26
- 2022-10-05
-
2022-10-12
Survey response — day 28, dose 5MedDRA: Gastrointestinal disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening GI symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
- 2022-10-25
- 2022-12-14
-
2023-03-13
Survey response — 6 months, dose 5MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-13
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-14
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-09-17 | Pfizer-BioNTech | No |
| 4 | 2022-03-26 | Pfizer-BioNTech | No |
| 5 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
6 call center cases
4 successful · 2 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Itchy throat 30 minutes after vaccine lasting 12 hours
Systemic reaction (other): Bloody nose
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Nose bleed
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Shaking
Systemic reaction (other): Bloody nose, insomnia with chills
Systemic reaction (other): Insomnia
Systemic reaction (other): Insomnia and stomach upset
Release 8 — day 21, dose 2
Symptoms: Low BP, exhaustion, diarrhea, migraines
Release 8 — day 28, dose 2
Symptoms: Stomach upset, low BP, low potassium
Release 8 — day 35, dose 2
Symptoms: Low grade fever, diarrhea, bladder discomfort, urinary pain
Release 9 — 3 months, dose 2
Symptoms: Respiratory virus rhinovirus, breast lump needing biopsy determined, SLE diagnosis
Release 10 — 6 months, dose 2
Symptoms: Weight loss, nausea, retina problem
Release 11 — 12 months, dose 2
Symptoms: Gastrointestinal complications, nosebleed
Release 11 — day 42, dose 4
Symptoms: Additional GI complications
Release 12 — day 28, dose 5
Symptoms: Worsening GI symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Bladder discomfort | ✓ | ✓ | ✓ |
| SD | Blood potassium decreased | ✓ | ✓ | ✓ |
| SD | Breast mass | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dysuria | ✓ | ✓ | ✓ |
| SD | Epistaxis | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Hypotension | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Retinal disorder | · | · | ✓ |
| SD | Rhinovirus infection | · | · | ✓ |
| SD | Systemic lupus erythematosus | · | · | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SRO | Abdominal discomfort | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Throat irritation | ✓ | ✓ | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release